Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Justin Warner

Surgery Naples, FL Medical Doctor

NPI 1548368020 CMS profile 342786

2335 Tamiami Trail N, Suite 501, Naples, FL 34103

Open in the dashboard

General payments

$37,226

96 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Warner of Naples, FL is reported in the CMS Open Payments database as having received $37,226 across 96 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,698 7
2024 General $429 8
2023 General $8,920 18
2022 General $10,068 29
2021 General $16,111 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Warner
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Justin Warner were reported at $1,698. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Justin Warner Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $0 $131 $40–$706 $114
2021 $16,111 $168 $50–$904 $132
2022 $10,068 $224 $76–$1,218 $149
2023 $8,920 $253 $82–$1,255 $160
2024 $429 $279 $90–$1,381 $164
2025 $1,698 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intuitive Surgical, Inc. $34,901 57 payments
  2. Medtronic, Inc. $1,615 16 payments
  3. Davol Inc. $242 4 payments
  4. Integra LifeSciences Corporation $124 3 payments
  5. Innocoll Incorporated $118 5 payments
  6. Baxter Healthcare $45 1 payment
  7. Heron Therapeutics, Inc. $32 2 payments
  8. Reprise Biomedical, Inc. $23 1 payment
  9. Distalmotion US $22 1 payment
  10. Abbott Laboratories $21 1 payment
  11. Other $83 5 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Education $28,500 11 payments
  2. Travel and Lodging $5,995 32 payments
  3. Food and Beverage $2,731 53 payments
Products named General payments · program years 2021–2025
  1. DAVINCI XI $15,500 7 payments
  2. Da Vinci Surgical System Surgery $13,000 4 payments
  3. Da Vinci Surgical System Surgery $6,401 46 payments
  4. Phasix Mesh $242 4 payments
  5. ProGrip $141 3 payments
  6. Integra Recon-Skin And Wound $124 3 payments
  7. Integra Recon-Skin And Wound $124 3 payments
  8. INTEGRA DERMAL REGENERATION TEMPLATE $124 3 payments
  9. OMNIGRAFT $124 3 payments
  10. SURGIMEND $124 3 payments
  11. Other $421 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

456

Median for General Surgery: 59

Drug cost

$4,898

Median for General Surgery: $393

Branded share of claims

89.9%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 34 $2,289
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 319 $1,443
Erythromycin Erythromycin Base Brand 29 $710
Neomycin Sulfate Generic 33 $173
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 13 $158
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 15 $86
Tramadol Hcl Generic 13 $40

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 103 billing codes

Paid by Medicare

$294,697

Medicare's payments for the services billed

Medicare patients

585

Average age 76

Services billed

1,106

240 women, 345 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 52%
Ischemic heart disease 44%
Cancer 27%
Diabetes 24%
Depression 22%
Chronic kidney disease 21%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

96 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record